Purchase Order 75N91025P00055

Award Date 5/1/25
Potential Completion Date 4/30/26
Potential Value $11K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The $10,188.00 contract is for a service agreement with a completion date of May 13, 2025. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is an experienced federal contractor that provides a variety of...
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services. The contract has a ceiling value of $15,159.00 and is for a maintenance agreement, with a period of performance ending on September 16, 2022. The prime contractor is Bio-Rad Laboratories, Inc., a global leader in developing and manufacturing products for life science research and clinical diagnostics....
Bio-Rad Laboratories, Inc. Life Science Group Division was awarded an $11,619.77 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Cancer Institute on April 1, 2019. The contract has a completion date of January 31, 2024 and no set-aside designation was used. This purchase order is associated with Bio-Rad Laboratories' five-year, $1 billion blanket purchase agreement with the Department of Health and Human Services National...
This contract was awarded by the National Institutes of Health (NIH) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the publicly traded life sciences company Bio-Rad Laboratories, Inc. The $22,853.96 firm-fixed-price purchase order does not have a set-aside designation. It provides for the delivery of various biological research products and associated maintenance services to the NIH. Bio-Rad Laboratories, Inc. holds a $1 billion Blanket Purchase Agreement with the...
This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc., is for the provision of various products and services to support biomedical research and testing. The $10,212.75 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. holds a major $1...
This $16,238.00 firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development, a civilian agency within the Department of Health and Human Services, to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The award does not have a set-aside designation. Bio-Rad Laboratories, Inc. is a leading global manufacturer of products for life science research and clinical diagnostics, including PCR systems, reagents, and other laboratory equipment and...
This federal contract award is for a maintenance agreement on various laboratory equipment, valued at $30,087.45, awarded by the National Cancer Institute (NCI) to Bio-Rad Laboratories, Inc. Life Science Group Division. The contract has an ultimate completion date of March 31, 2025. Bio-Rad Laboratories, Inc. is the parent company of the prime contractor and has established significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with various federal agencies,...
This is a $346,770.62 firm fixed price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The contract is for the Laboratory of Receptor Biology and Gene Expression (LRGBE) to elucidate the mechanisms involved in the regulation of genetic expression in eukaryotic cells and identify the genes and regulatory processes involved in modulated states of expression. The...
This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc., is a Blanket Purchase Agreement (BPA) call with the National Cancer Institute, a component of the National Institutes of Health (NIH), with a ceiling value of $1,337.42. The contract, which does not have a set-aside designation, is for the provision of various products and services related to biomedical research and testing, including...
This contract award to Bio-Rad Laboratories, Inc. Life Science Group Division is for $24,995.00 to provide laboratory equipment and supplies to the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The award is a Blanket Purchase Agreement (BPA) call contract with a firm fixed price pricing type. This contract is not set aside for any specific business category. Bio-Rad Laboratories, Inc. is a leading manufacturer and supplier of specialized equipment,...

This is a $10,783.00 firm fixed-price service agreement awarded to Bio-Rad Laboratories, Inc., a global leader in scientific instrumentation and laboratory supplies, by the National Cancer Institute. The contract is for the delivery of unspecified products and services related to the agency's research activities, with a period of performance through April 2026. The contract is not set aside for small businesses. Bio-Rad Laboratories, Inc. holds a significant $1 billion blanket purchase agreement with the National Institutes of Health for the procurement of biological materials, laboratory supplies, and other operational items, which further supports the company's role as a critical supplier to federal research agencies.

Generated 4/29/25, 9:44 AM